Triple-Phase MDCT of Hepatocellular Carcinoma
K. H. Y. Lee1,
M. E. O'Malley1,2,
M. A. Haider1 and
A. Hanbidge1
1 Department of Medical Imaging, University Health Network and Mount Sinai
Hospital, University of Toronto, Toronto, ON, Canada.
2 Department of Medical Imaging, NCSB, 1C558, Toronto General Hospital, 585
University Ave., Toronto M5G 2N2, ON, Canada.

View larger version (166K):
[in a new window]
|
Fig. 1A. 58-year-old woman with chronic hepatitis B. Hepatic arterial
(A) and portal venous (B) phase MDCT scans show large
hepatocellular carcinoma in right lobe of liver. Tumor is heterogeneous during
both phases. Note hypervascular components (arrow) on A that
show washout on B.
|
|

View larger version (160K):
[in a new window]
|
Fig. 1B. 58-year-old woman with chronic hepatitis B. Hepatic arterial
(A) and portal venous (B) phase MDCT scans show large
hepatocellular carcinoma in right lobe of liver. Tumor is heterogeneous during
both phases. Note hypervascular components (arrow) on A that
show washout on B.
|
|

View larger version (8K):
[in a new window]
|
Fig. 2. Graph shows mean attenuation of lesions (long-dashed
lines), liver (short-dashed lines), and aorta (solid
line) during hepatic arterial and portal venous phases. Note that mean
attenuation of liver increases while mean attenuation of lesions decreases on
portal venous phase compared with hepatic arterial phase.
|
|

View larger version (141K):
[in a new window]
|
Fig. 3A. 46-year-old man with chronic hepatitis B. Hepatic arterial
phase MDCT scan shows large heterogeneous hepatocellular carcinoma
(arrowheads) with hypervascular components and abnormal internal
vessels (arrow).
|
|

View larger version (145K):
[in a new window]
|
Fig. 3B. 46-year-old man with chronic hepatitis B. Portal venous phase
MDCT scan shows heterogeneous tumor (arrowheads) that is
predominantly hypoattenuating relative to liver parenchyma.
|
|

View larger version (165K):
[in a new window]
|
Fig. 4A. 79-year-old man with underlying alcoholic cirrhosis. Hepatic
arterial phase MDCT scan shows hypoattenuating tumor in segments II and
III.
|
|

View larger version (181K):
[in a new window]
|
Fig. 4B. 79-year-old man with underlying alcoholic cirrhosis. Portal
phase MDCT scan shows tumor to be predominantly hypoattenuating with
peripheral crescent of tissue that is isoattenuating to liver parenchyma.
|
|

View larger version (107K):
[in a new window]
|
Fig. 5A. 70-year-old man with chronic hepatitis B. Hepatic arterial
(A) and portal venous (B) phase MDCT scans show hepatocellular
carcinoma with hypervascular nodule (arrow) in A that remains
hyperattenuating relative to liver in B.
|
|

View larger version (122K):
[in a new window]
|
Fig. 5B. 70-year-old man with chronic hepatitis B. Hepatic arterial
(A) and portal venous (B) phase MDCT scans show hepatocellular
carcinoma with hypervascular nodule (arrow) in A that remains
hyperattenuating relative to liver in B.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Copyright © 2004 by the American Roentgen Ray Society.